Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Rett Syndrome, RTT
In brief
To evaluate the efficacy of cannabidiol oral solution (GWP42003-P, CBD-OS) in reducing symptom severity when compared with placebo, in participants with Rett syndrome.
Key facts
- Study ID
- NCT03848832
- Run by
- Jazz Pharmaceuticals
- People needed
- 29
- Starts
- 2019-07-29
- Expected to finish
- 2021-01-21
- Last updated by the study team
- 2022-09-02
Who can join
Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Trial Site — Birmingham, Alabama, United States
- Clinical Trial Site — San Diego, California, United States
- Clinical Trial Site — Aurora, Colorado, United States
- Clinical Trial Site — Chicago, Illinois, United States
- Clinical Trial Site — Baltimore, Maryland, United States
- Clinical Trial Site — Boston, Massachusetts, United States
- Clinical Trial Site — Saint Paul, Minnesota, United States
- Clinical Trial Site — St Louis, Missouri, United States
- Clinical Trial Site — The Bronx, New York, United States
- Clinical Trial Site — Cincinnati, Ohio, United States
- Clinical Trial Site — Philadelphia, Pennsylvania, United States
- Clinical Trial Site — Greenwood, South Carolina, United States
- Clinical Trial Site — Nashville, Tennessee, United States
- Clinical Trial Site — Houston, Texas, United States
- Clinical Trial Site — Genoa, Italy
- Clinical Trial Site — Messina, Italy
- Clinical Trial Site — Milan, Italy
- Clinical Trial Site — Rome, Italy
- Clinical Trial Site — Barcelona, Spain
- Clinical Trial Site — Barcelona, Spain
- Clinical Trial Site — Madrid, Spain
- Clinical Trial Site — Madrid, Spain
- Clinical Trial Site — Valencia, Spain
- Clinical Trial Site — Liverpool, United Kingdom
- Clinical Trial Site — London, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.